Friday, February 21, 2025

Investor Ideas New Stocks to Watch in Mining; (OTCQX: $LUCMF; TSX-V: $LUCA.V), (NASDAQ: $NVA), (OTCQX: $SRBIF; TSX: $SBI.TO), (OTCQX: $RIOFF; TSXV: $RIO.V), (LON: $FCM.L), (CSE: $BFG.CN), (Nasdaq: $SSRM; TSX: $SSRM.TO) (CSE: $LECR.CN)

Investor Ideas New Stocks to Watch in Mining; (OTCQX: $LUCMF; TSX-V: $LUCA.V), (NASDAQ: $NVA), (OTCQX: $SRBIF; TSX: $SBI.TO), (OTCQX: $RIOFF; TSXV: $RIO.V), (LON: $FCM.L), (CSE: $BFG.CN), (Nasdaq: $SSRM; TSX: $SSRM.TO) (CSE: $LECR.CN)


 

 



 

February 21, 2025 – (Investorideas.com Newswire) Investorideas.com, a global news source and expert investing resource, announces today’s roundup of stocks to watch in the mining sector.

 

The newest mining companies are involved in gold, silver, copper and REE (Rare Earth Elements) exploration across the Americas.

 

New stocks added today:

Luca Mining (OTCQX: LUCMF) (TSX-V: LUCA), Nova Minerals Limited (NASDAQ: NVA), Serabi Gold PLC (OTCQX: SRBIF; TSX: SBI), RIO2 Limited (OTCQX: RIOFF; TSXV: RIO), First Class Metals (LON:FCM), Giant Mining Corp. (CSE:BFG), SSR Mining Inc. (Nasdaq:SSRM; TSX:SSRM; ASX:SSR), Leocor Mining Inc. (CSE:LECR)

 

Read this in full at https://www.investorideas.com/news/2025/mining/02211New-Stocks-to-Watch.asp

 

Investor Ideas is always researching and searching for new stocks to add to our growing list of free stock directories. The directories are not meant as recommendations but as a research tool to discover opportunities and trading ideas in a particular sector.

 

New Stocks Added to the Mining Directories:

Luca Mining (OTCQX: LUCMF) (TSX-V: LUCA) is a diversified Canadian mining company with two 100%-owned producing mines within the prolific Sierra Madre mineralized belt in Mexico which hosts numerous producing and historic mines along its trend. The Company produces gold, copper, zinc, silver and lead from these mines that each have considerable development and resource upside.

 

Nova Minerals Limited (NASDAQ: NVA) is a Gold, Antimony and Critical Minerals exploration and development company focused on advancing the Estelle Project, comprised of 514 km2 of State of Alaska mining claims, which contains multiple mining complexes across a 35 km long mineralized corridor of over 20 advanced Gold and Antimony prospects, including two already defined multi-million ounce resources, and several drill ready Antimony prospects with massive outcropping stibnite vein systems observed at surface. The 85% owned project is located 150 km northwest of Anchorage, Alaska, USA, in the prolific Tintina Gold Belt, a province which hosts a >220 million ounce (Moz) documented gold endowment and some of the world's largest gold mines and discoveries including, Barrick's Donlin Creek Gold Project and Kinross Gold Corporation's Fort Knox Gold Mine. The belt also hosts significant Antimony deposits and was a historical North American Antimony producer.

 

Serabi Gold PLC (OTCQX: SRBIFTSX: SBI) is a gold exploration, development and production company focused on the prolific Tapajós region in Para State, northern Brazil. The Company has consistently produced 30,000 to 40,000 ounces per year with the Palito Complex and is planning to double production in the coming years with the construction of the Coringa Gold project. Serabi Gold plc recently made a copper-gold porphyry discovery on its extensive exploration licence. The Company is headquartered in the United Kingdom with a secondary office in Toronto, Ontario, Canada.

 

RIO2 Limited (OTCQX: RIOFFTSXV: RIO) is a mining company with a focus on development and mining operations with a team that has proven technical skills as well as successful capital markets track record. Rio2 is focused on taking its Fenix Gold Project in Chile to production in the shortest possible timeframe based on a staged development strategy. Rio2 and its wholly owned subsidiary, Fenix Gold Limitada, are companies with the highest environmental standards and responsibility with the firm conviction that it is possible to develop mining projects that respect the three pillars (Social, Environment, Economics) of responsible development. As related companies, we reaffirm our commitment to apply environmental standards beyond those that are mandated by regulators, seeking to protect and preserve the environment of the territories that we operate in.

 

First Class Metals (LON:FCM) is focused on metals exploration in Ontario, Canada which has

a robust and thriving junior mineral exploration sector. In particular, the Hemlo 'camp' near Marathon, Ontario is a proven world class address for gold exploration, featuring the Hemlo gold deposit operated by Barrick Gold (>23M oz gold produced), with the past producing Geco and Winston Lake base metal deposits also situated in the region. FCM currently holds 100% ownership of seven claim blocks covering over 180km² along a 150km strike of the

Hemlo-Schreiber-Dayohessarah greenstone belt, exploring for gold, base metals, and rare earth element mineralization. In addition, FCM is carrying out a joint venture with Palladium One on the West Pickle Lake Property in the region, a drill-proven ultra-high-grade Ni-Cu project.

 

Giant Mining Corp. (CSE:BFG) is focused on identifying, acquiring, and advancing late-stage copper and copper/silver/gold projects to meet the growing global demand for critical metals. This demand is driven by initiatives like the Green New Deal in the United States and similar climate-focused programs worldwide, which require substantial amounts of copper, silver, and gold for electric vehicles, renewable energy infrastructure, and the modernization of clean and affordable energy systems. The Company’s flagship asset is the Majuba Hill Copper, Silver, and Gold District, located 156 miles (251 km) from Reno, Nevada. Majuba Hill is situated in a mining-friendly jurisdiction with supportive regulations and has the potential to become one of the next major copper deposits, critical for meeting the increasing need for this red metal.

 

SSR Mining Inc. (Nasdaq:SSRMTSX:SSRM; ASX:SSR) is an intermediate gold company with assets located in four jurisdictions: the USA, Türkiye, Canada, and Argentina. These assets are located within several of the world’s most prolific precious metal districts including the Çöpler mine along the Tethyan belt in Türkiye; the Marigold mine along the Battle Mountain-Eureka trend in Nevada, USA; the Seabee mine along the Trans-Hudson Corridor in Saskatchewan, Canada; and the Puna mine along the Bolivian silver belt in Jujuy, Argentina.

 

Leocor Mining Inc. (CSE:LECR) is a British Columbia-based resource company involved in the acquisition and exploration of precious metal projects, with a current focus in Atlantic Canada. Leocor, through outright ownership and earn-in agreements, currently controls several gold-copper projects in prime exploration ground located within the prolific Baie Verte Mining District. Leocor’s Bae Verte portfolio includes the Dorset, Dorset Extension, Copper Creek and Five Mile Brook projects, creating a contiguous nearly 2,000-hectare exploration corridor. The Company also controls district scale land packages in North Central Newfoundland, known as Robert’s Arm, Hodge’s Hill, and Leamington, (collectively “Western Exploits”) representing over 144,000 hectares (1,440 square kilometers) of prospective exploration ground.

 

 

 



Check out the Exploring Mining podcast by Investor Ideas for the latest mining stock news and insightful interviews with top industry experts







Get more 
mining stock investor ideas- news, articles, podcasts and stock directories

 

 

 

About Investorideas.com - Big Investing Ideas

Investorideas.com is the go-to platform for big investing ideas. From breaking stock news to top-rated investing podcasts, we cover it all. Our original branded content includes podcasts such as Exploring Mining, Cleantech, Crypto Corner, Cannabis News, and the AI Eye. We also create free investor stock directories for various sectors, including gaming, biotech, tech and sports. Public companies within the sectors we cover can use our news publishing and content creation services to help tell their story to interested investors. Paid content is always disclosed.

 

Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investing involves risk and possible losses. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. Contact management and IR of each company directly regarding specific questions. More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp Learn more about publishing your news release and our other news services on the Investorideas.com newswire https://www.investorideas.com/News-Upload/

Global investors must adhere to regulations of each country. Please read Investorideas.com privacy policy: https://www.investorideas.com/About/Private_Policy.asp

 

Learn more about our news, PR and social media, podcast services at Investorideas.com

https://www.investorideas.com/Investors/Services.asp

 

Learn more about advertising and guest posts

https://www.investorideas.com/Advertise/

 

Follow us on Twitter (X) https://X.com/Investorideas

Follow us on Facebook https://www.facebook.com/Investorideas

Follow us on YouTube https://www.youtube.com/c/Investorideas

 

Contact Investorideas.com to be added to our stock directories or learn more about us

Dawn Van Zant and Cali Van Zant

 

800 665 0411

 

 



 

 

 

 

 

 

 

 

 

 


Tuesday, February 18, 2025

Cleantech and Climate Change Podcast - Evan Caron, CIO at Montauk Climate Talks about the Intersection of Cleantech and infrastructure

 

 

Cleantech and Climate Change Podcast - Evan Caron, CIO at Montauk Climate Talks about the Intersection of Cleantech and infrastructure

 



 

 

February 18, 2025 – (Investorideas.com Newswire) Investorideas.com, a global news source and expert investing resource covering water and renewable energy stocks issues a new edition of the Investorideas.com Cleantech Podcast.

 

Host Dawn Van Zant talks to Evan Caron , a 20-year energy and commodities veteran and co-founder / CIO at Montauk Climate, an incubator building companies at the intersection of clean tech and infrastructure.

 

Listen to the podcast on Spreaker

https://www.spreaker.com/episode/evan-caron-cio-at-montauk-climate-talks-about-the-intersection-of-cleantech-and-infrastructure--64438960

 

Watch the Interview on YouTube

https://www.youtube.com/watch?v=sNpxc3SZcCA&t

 


Read this in full at https://www.investorideas.com/news/2025/cleantech-podcasts/02181Evan-Caron-of-Montauk-Climate.asp

 

Listen to the Cleantech Podcast at Investorideas.com on Spotify

 

Overview:

Evan shares the strategy at Montauk to invest in the intersection of energy, balancing cleantech with other energy sources and solutions.  He says the first time the history of modern history that there is an intersection with new energy technologies like solar and wind, batteries, the electrification of vehicles and the big one, energy and A!.  “

 

 He talks about the direction of the new Trump administration and a more pragmatic approach with energy and that instead of mandates for zero emissions it will seek innovation that is cost effective..

 

He says retail investors can follow their model by investing in ETF’s and companies that provide more than one solution and have fuel mixed portfolios around the energy transition.

 

He closes with two things to always remember, “Don’t fight the fed and don’t fight a trend where hundreds of billions of dollars will be deployed; follow the money. We are still very much in the early innings,”

 

Evan was previously Head of Venture Investments at Riverstone Private Equity, a $40 Billion+ energy investment and infrastructure firm.

 

He co-founded Montauk along with Philp Krim (ex-Casper CEO) and Sharo Atmeh (ex-Alyeska Investment Group).

 

Host Dawn Van Zant is a female pioneer in the financial markets sitting in every seat as a trader, a broker, IR and PR before finally starting my own site. Van Zant has been featured in interviews in Business Week, CNN Financial TV, CBS Market watch radio and other financial publications online, radio and print, talking about renewable energy, water and defense stocks.

 

Hear other editions of the cleantech podcast at Investorideas.com



 

Research renewable energy stocks at Investorideas

https://www.investorideas.com/Companies/RenewableEnergy/Stock_List.asp

Research water stocks at Investorideas

https://www.investorideas.com/Water-Stocks/Stock_List.asp

The Investorideas.com podcasts are also available on Apple Podcasts, Audible, Spotify, Tunein, Stitcher, Spreaker.com, iHeartRadio, Google Podcasts and most audio platforms available.

 

Visit the Podcast page at Investorideas.com:

https://www.investorideas.com/Audio/

 

About Investorideas.com - Big Investing Ideas

Investorideas.com is the go-to platform for big investing ideas. From breaking stock news to top-rated investing podcasts, we cover it all. Our original branded content includes podcasts such as Exploring Mining, Cleantech, Crypto Corner, Cannabis News, and the AI Eye. We also create free investor stock directories for sectors including mining, crypto, renewable energy, gaming, biotech, tech, sports and more. Public companies within the sectors we cover can use our news publishing and content creation services to help tell their story to interested investors. Paid content is always disclosed.

Disclaimer/DisclosureOur site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investing involves risk and possible losses. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. Contact management and IR of each company directly regarding specific questions. More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp Learn more about publishing your news release and our other news services on the Investorideas.com newswire https://www.investorideas.com/News-Upload/

Global investors must adhere to regulations of each country. Please read Investorideas.com privacy policy: https://www.investorideas.com/About/Private_Policy.asp

 

Learn more about our news, PR and social media, podcast services at Investorideas.com

https://www.investorideas.com/Investors/Services.asp

 

Follow us on X @investorideas

Follow us on Facebook https://www.facebook.com/Investorideas

Follow us on YouTube https://www.youtube.com/c/Investorideas

 

Contact Investorideas.com

800 665 0411

 

 


Get more 
Renewable Energy Stock news, articles, podcasts and Stock Directories

 

 

 

 

 

 


Friday, February 14, 2025

Investor Ideas New Stocks to Watch in Life Sciences and AI; (TSXV: $ZCT.V) (TSXV: $IOT.V) (Nasdaq: $SPRC) (OTCQB: $BIXT) (NASDAQ: $KITT) (TSX-V: $XBOT.V; OTC: $XBOTF) (OTCQB: $WYTC) (OTCQB: $RELT)

Investor Ideas New Stocks to Watch in Life Sciences and AI; (TSXV: $ZCT.V) (TSXV: $IOT.V) (Nasdaq: $SPRC) (OTCQB: $BIXT) (NASDAQ: $KITT) (TSX-V: $XBOT.V; OTC: $XBOTF) (OTCQB: $WYTC) (OTCQB: $RELT)

 



 


February 14, 2025 – (Investorideas.com Newswire) Investorideas.com, a global news source and expert investing resource, announces today’s roundup of stocks to watch in the Life Sciences and AI sectors.

 

The newest life sciences companies are involved in woman’s health, microbiology testing, cannabinoid pharmaceuticals and drug development using AI.

 

The latest AI companies are involved in autonomous robotics, AI/sensor technology and marketing and business solutions.

 

New stocks added today: Zero Candida Technologies Inc. (TSXV:ZCT), Innovotech, Inc. (TSXV: IOT), SciSparc Ltd. (Nasdaq: SPRC), Bioxytran, Inc. (OTCQB: BIXT) Nauticus Robotics, Inc. (NASDAQ:KITT), Realbotix Corp. (TSX-V: XBOT; OTC: XBOTF), Wytec International, Inc. (OTCQB: WYTC), Onar, Inc. (OTCQB: RELT).

 

Read this in full at https://www.investorideas.com/news/2025/main/02141Stocks.asp

 

 

Investor Ideas is always researching and searching for new stocks to add to our growing list of free stock directories. The directories are not meant as recommendations but as a research tool to discover opportunities and trading ideas in a particular sector.

 

New Stocks Added to the Life Sciences/Biotech Directories:

Zero Candida Technologies Inc. (TSXV:ZCT) is a publicly traded FemTech company pioneering innovative solutions in women's health. The company is developing an AI-driven, tampon-like device that uses a therapeutic light source with a selected wave-length and intensity to effectively treat the Candida fungus with a demonstrated 99.999% success rate in POC.  Vulvo-Vaginal Candidiasis ("VVC") affects about 75% of women globally, with 138witheach year 138 million women are affected world-wide and 492 million over their lifetime. Recurrent VVC (4 or more episodes per year) is increasingly documented to become drug resistant to existing treatments, since the root cause is poorly understood and addressed.  ZCT has successfully completed a safety trial using its pre-clinical device in large animals (sheep), and is finalizing their device for human use in preparation for an upcoming clinical trial, that they secured both funding and agreements with leading hospitals in Israel and Europe for. The Company continues to grow it's global patent portfolio with applications filed in the United States, Brazil and Europe, and was recently granted a final patent in South Africa. With hybrid medicine and technology-based diagnostics, ZCT is addressing unmet needs in women's healthcare and expanding access to underserved populations, bringing the field of gynecology into the 21st century.

 

Innovotech, Inc. (TSXV: IOT) is a Canadian biotechnology company owning proprietary intellectual property, conducting contract research, and owning and providing proprietary devices for testing in multiple applications in microbiology

 

SciSparc Ltd. (Nasdaq: SPRC) is a specialty clinical-stage pharmaceutical company led by an experienced team of senior executives and scientists. SciSparc’s focus is on creating and enhancing a portfolio of technologies and assets based on cannabinoid pharmaceuticals. With this focus, the Company is currently engaged in the following drug development programs based on THC and/or non-psychoactive cannabidiol: SCI-110 for the treatment of Tourette Syndrome, for the treatment of Alzheimer's disease and agitation; and SCI-210 for the treatment of autism and status epilepticus. The Company also owns a controlling interest in a subsidiary whose business focuses on the sale of hemp seeds’ oil-based products on the Amazon.com Marketplace.

 

Bioxytran, Inc. (OTCQB: BIXT) is a clinical stage biotechnology company pioneering a library of novel complex carbohydrate structures using artificial intelligence software that interprets the Nuclear Magnetic Resonance imaging of druggable targets like the galectin fold to create a rational drug design. The leading drug candidates vetted by in vitro testing, are capable of neutralizing viruses. The peer-reviewed discovery of the galectin fold located on the spike proteins of viruses such as COVID-19, RSV, and H1N1 demonstrate there exists a conserved region on the spike in which Bioxytran’s molecules achieve virus neutralization. The extent of the carbohydrate structure’s ability to neutralize untested viruses is unknown just like the initial discovery of antibiotics last century and its ability to treat a broad spectrum of bacterial infections. Applications of this platform technology extend to the treatment of significant unmet medical needs in virology, degenerative disease, and hypoxia. The leading drug candidate, Prolectin-M, is a new class of antiviral drug designed to antagonize galectins implicated in inflammatory, fibrotic, and malignant diseases. Bioxytran’s other development programs are for pulmonary fibrosis and stroke treatment.

 

New Stocks Added to the AI/Tech Directories:

Nauticus Robotics, Inc. (NASDAQ:KITT) develops autonomous robots for the ocean industries. Autonomy requires the extensive use of sensors, artificial intelligence, and effective algorithms for perception and decision allowing the robot to adapt to changing environments. The company's business model includes using robotic systems for service, selling vehicles and components, and licensing of related software to both the commercial and defense business sectors. Nauticus has designed and is currently testing and certifying a new generation of vehicles to reduce operational cost and gather data to maintain and operate a wide variety of subsea infrastructure. Besides a standalone service offering and forward-facing products, Nauticus' approach to ocean robotics has also resulted in the development of a range of technology products for retrofit/upgrading traditional ROV operations and other third-party vehicle platforms. Nauticus' services provide customers with the necessary data collection, analytics, and subsea manipulation capabilities to support and maintain assets while reducing their operational footprint, operating cost, and greenhouse gas emissions, to improve offshore health, safety, and environmental exposure.

 

Realbotix Corp. (TSX-V: XBOTOTC: XBOTF; FSE: 76M0.F) Transcending the barrier between man and machine, Realbotix creates customizable, full-bodied, humanoids with AI integration that improve the human experience through connection, learning and play. Manufactured in the USA, Realbotix has a reputation for having the highest quality humanoid robots and the most realistic silicone skin technology. Realbotix sells humanoid products with embedded AI to enable human-like social interactions and intimate connections with humans. Our integration of hardware and AI software results in the most human looking full-sized robots on this planet. We achieve this through patented technologies that deliver human-like appearance and movements. This versatility makes our robots and their personalities customizable and programmable to suit a wide variety of use cases.

 

Wytec International, Inc. (OTCQB: WYTC) is a 5G network development company with proprietary, patent, and patent-pending AI/sensor technology designed to support gunshot detection, drug sensing technology for public safety, and distance learning solutions for schools and cities.

 

Onar, Inc. (OTCQB: RELT) is a dynamic marketing and business solutions network, currently publicly traded as Reliant Holdings, Inc. with plans to become Onar Holding Corporation in the near future. ONAR's mission is to provide unparalleled service through an integrated, AI-driven approach, leveraging its diverse brand family's strengths. Committed to honor, candor, and best-in-class results, ONAR aims to lead the industry by example, ensuring every client relationship is deeply rooted in trust and excellence.

 

About Investorideas.com - Big Investing Ideas

Investorideas.com is the go-to platform for big investing ideas. From breaking stock news to top-rated investing podcasts, we cover it all. Our original branded content includes podcasts such as Exploring Mining, Cleantech, Crypto Corner, Cannabis News, and the AI Eye. We also create free investor stock directories for various sectors, including gaming, biotech, tech and sports. Public companies within the sectors we cover can use our news publishing and content creation services to help tell their story to interested investors. Paid content is always disclosed.

 

Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investing involves risk and possible losses. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. Contact management and IR of each company directly regarding specific questions. More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp Learn more about publishing your news release and our other news services on the Investorideas.com newswire https://www.investorideas.com/News-Upload/

Global investors must adhere to regulations of each country. Please read Investorideas.com privacy policy: https://www.investorideas.com/About/Private_Policy.asp

 

Learn more about our news, PR and social media, podcast services at Investorideas.com

https://www.investorideas.com/Investors/Services.asp

 

Learn more about advertising and guest posts

https://www.investorideas.com/Advertise/

 

Follow us on Twitter (X) https://X.com/Investorideas

Follow us on Facebook https://www.facebook.com/Investorideas

Follow us on YouTube https://www.youtube.com/c/Investorideas

 

Contact Investorideas.com to be added to our stock directories or learn more about us

Dawn Van Zant and Cali Van Zant

 

800 665 0411

 


 


 

 

 

 

 

 

 

 

 


Thursday, February 13, 2025

Breaking Medical Technology News: Aethlon Medical (NASDAQ: $AEMD) to Present at the Emerging Growth Conference on February 19, 2025

 

Breaking Medical Technology News: Aethlon Medical (NASDAQ: $AEMD) to Present at the Emerging Growth Conference on February 19, 2025

 

Aethlon Medical invites individual and institutional investors as well as advisors and analysts, to attend its real-time, interactive presentation at the Emerging Growth Conference

 


SAN DIEGO,CA - February 13, 2025 (Investorideas.com Newswire) Aethlon Medical, Inc. (Nasdaq: AEMD), a medical therapeutic company focused on developing products to treat cancer and life-threatening infectious diseases, is pleased to announce that it has been invited to present on the Emerging Growth Conference on February 19, 2025.

 

This live, interactive online event will give existing shareholders and the investment community the opportunity to interact with Aethlon Medical's Chief Executive Officer, Mr. James Frakes, in real time.

 

Mr. Frakes will perform a presentation and may subsequently open the floor for questions. Please submit your questions in advance to Questions@EmergingGrowth.com or ask your questions during the event and Mr. Frakes will do his best to get through as many of them as possible.

 

Paid News Dissemination of behalf of AEMD.

 

Read this news, featuring AEMD in full at https://www.investorideas.com/news/2025/02131AEMD-Present-at-the-Emerging-Growth-Conference.asp

 

Aethlon Medical, Inc. will be presenting at 11:25 AM Eastern time for 30 minutes.

Please register here to ensure you are able to attend the conference and receive any updates that are released:

https://goto.webcasts.com/starthere.jsp?ei=1696664&tp_key=a17d7ff4c2&sti=aemd

 

If attendees are not able to join the event live on the day of the conference, an archived webcast will also be made available on EmergingGrowth.com and on the Emerging Growth YouTube Channel, http://www.YouTube.com/EmergingGrowthConference. We will release a link to that after the event.

 

About the Emerging Growth Conference

The Emerging Growth conference is an effective way for public companies to present and communicate their new products, services and other major announcements to the investment community from the convenience of their office, in a time efficient manner.

The conference focus and coverage includes companies in a wide range of growth sectors, with strong management teams, innovative products & services, focused strategy, execution, and the overall potential for long term growth. Its audience includes potentially tens of thousands of Individual and Institutional investors, as well as Investment advisors and analysts.

 

All sessions will be conducted through video webcasts and will take place in the Eastern time zone.

 

About Aethlon and the Hemopurifier®

Aethlon Medical is a medical therapeutic company focused on developing the Hemopurifier, a clinical stage immunotherapeutic device which is designed to combat cancer and life-threatening viral infections and for use in organ transplantation. In human studies, the Hemopurifier has demonstrated the removal of life-threatening viruses and in pre-clinical studies, the Hemopurifier has demonstrated the removal of harmful exosomes from biological fluids, utilizing its proprietary lectin-based technology. This action has potential applications in cancer, where exosomes may promote immune suppression and metastasis, and in life-threatening infectious diseases. The Hemopurifier is a U.S. Food and Drug Administration (FDA) designated Breakthrough Device indicated for the treatment of individuals with advanced or metastatic cancer who are either unresponsive to or intolerant of standard of care therapy, and with cancer types in which exosomes have been shown to participate in the development or severity of the disease. The Hemopurifier also holds an FDA Breakthrough Device designation and an open Investigational Device Exemption (IDE) application related to the treatment of life-threatening viruses that are not addressed with approved therapies.

 

Additional information can be found at www.AethlonMedical.com.

 

Company Contact:
Jim Frakes
Chief Executive Officer and Chief Financial Officer
Aethlon Medical, Inc.
Jfrakes@aethlonmedical.com

 

Investor Contact:
Susan Noonan
S.A. Noonan Communications, LLC
susan@sanoonan.com

 

SOURCE Aethlon Medical, Inc.

 

Aethlon Medical Inc. (Nasdaq:AEMD) is a featured biotech stock on Investorideas.com

 

More info on AEMD at Investorideas.com Visit: 

https://www.investorideas.com/CO/AEMD/

 

Get News Alerts on Aethlon Medical

 

Disclaimer/Disclosure: Athelon Medical, Inc. (AEMD) is a paid featured  medical tech stock on Investor ideas  More disclosure:Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investing involves risk and possible losses. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. More disclosure: Contact management and IR of each company directly regarding specific questions.

 

 



Biotech Industry Stocks- investing ideas in biotechnology stocks, medical technology and life sciences

Get more biotech and medical tech news, articles, podcasts and stock directories